Search - tctmd.com

Displaying 661 - 680 of 1207

Sort: Relevancy | Date

News Daily News

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Michael O'Riordan

March 14, 2016

News Industry News

Boston Scientific Receives U.S. FDA Approval For Blazer™ Open-Irrigated Catheter

March 10, 2016

News Daily News

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Michael O'Riordan

March 08, 2016

News Daily News

关于实验性高危心血管装置的研究越来越多

Shelley Wood

March 02, 2016

News Daily News

More Studies of Investigational High-Risk Cardiovascular Devices are Getting Published

Shelley Wood

March 02, 2016

News Daily News

Hay Cada Vez Más Estudios sobre Dispositivos Cardiovasculares de Alto Riesgo en Fase de Investigación

Shelley Wood

March 02, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

March 01, 2016

News Daily News

MitraClip Manufacturer Issues Safety Notice on Proper Deployment

Caitlin E. Cox

February 28, 2016

News Conference News CRT 2016

Health Apps, Bar Codes, and Big Data: The “Brave New World” of Medical Device Innovation

Shelley Wood

February 23, 2016

News Daily News

Cardiologist Robert Califf Becomes New Commissioner of the FDA

L.A. McKeown

February 23, 2016

News Daily News

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Yael L. Maxwell

February 22, 2016

News Industry News

Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia

February 22, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

L.A. McKeown

February 21, 2016

News Daily News

FDA Advisors Recommend Comprehensive, Long-Term Study of Leadless Pacemakers

Yael L. Maxwell

February 18, 2016

News Daily News

Undisclosed Clinical Trial Results Across All Major Academic Medical Centers: “A Failed Moral Obligation”

Michael O'Riordan

February 17, 2016

News Industry News

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

February 17, 2016

News Industry News

St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology

February 16, 2016

Advertisement

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Boston Scientific Receives U.S. FDA Approval For Blazer™ Open-Irrigated Catheter

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

关于实验性高危心血管装置的研究越来越多

More Studies of Investigational High-Risk Cardiovascular Devices are Getting Published

Hay Cada Vez Más Estudios sobre Dispositivos Cardiovasculares de Alto Riesgo en Fase de Investigación

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

MitraClip Manufacturer Issues Safety Notice on Proper Deployment

Health Apps, Bar Codes, and Big Data: The “Brave New World” of Medical Device Innovation

Cardiologist Robert Califf Becomes New Commissioner of the FDA

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

FDA Advisors Recommend Comprehensive, Long-Term Study of Leadless Pacemakers

Undisclosed Clinical Trial Results Across All Major Academic Medical Centers: “A Failed Moral Obligation”

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content